KCM
ZSAN

Knoll Capital Management’s Zosano Pharma Corporation ZSAN Stock Holding History

Knoll Capital Management’s Portfolio ZSAN Stock Details ZSAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-16
Closed -$15K – 22
2016
Q2 		$15K Sell
16
-11
-41% -$14.2K ﹤0.01% 22
2016
Q1 		$43K Hold
27
– – 0.02% 21
2015
Q4 		$42K Hold
27
– – 0.02% 20
2015
Q3 		$74K Sell
27
-2
-7% -$11.2K 0.03% 18
2015
Q2 		$145K Hold
29
– – 0.05% 18
2015
Q1 		$202K Buy
+29
New +$218K 0.06% 16

Other funds holding ZSAN

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
LOAMU
Lombard Odier Asset Management (USA) New York $957M AUM 35.8% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

Knoll Capital Management's ZSAN Position: Q3 2016 in Review

Knoll Capital Management sold out of Zosano Pharma Corporation (ZSAN) in Q3 2016, closing a stake of 16 shares — an estimated $15K sold.

Knoll Capital Management first reported a position in ZSAN in Q1 2015 and held it in 6 quarters. The position peaked at $202K in Q1 2015. 14 funds tracked by Wall St. Rank hold ZSAN as of Q3 2016.

  • Knoll Capital Management reported no remaining Zosano Pharma Corporation position as of Q3 2016 after selling out during the quarter.
  • Knoll Capital Management sold 16 Zosano Pharma Corporation shares in Q3 2016, an estimated $15K.
  • Knoll Capital Management first reported a position in Zosano Pharma Corporation in Q1 2015 and held it in 6 quarters.
  • Knoll Capital Management's Zosano Pharma Corporation position peaked at $202K in Q1 2015.
  • 14 funds tracked by Wall St. Rank held Zosano Pharma Corporation as of Q3 2016.

Based on Knoll Capital Management's 13F filing for Q3 2016, filed 14 Nov 2016.